Tokyo, Japan

Naoko Kamimura


 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Toshima-ku, Tokyo, JP (2010)
  • Tokyo, JP (2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naoko Kamimura: Innovator in Cancer Research

Introduction

Naoko Kamimura is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of cancer research, particularly through her innovative patents. With a total of two patents to her name, Kamimura's work focuses on the diagnosis and treatment of cancer.

Latest Patents

Kamimura's latest patents revolve around a gene that is overexpressed in cancer. These patents disclose a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof. Additionally, they include an antibody recognizing the protein or an antigen-binding fragment thereof, as well as a polynucleotide with a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a complementary nucleotide sequence. The gene and protein of her invention are useful for diagnosing and treating cancer.

Career Highlights

Throughout her career, Naoko Kamimura has worked with various organizations, including Perseus Proteomics Inc. Her expertise in the field has allowed her to contribute valuable insights and advancements in cancer research.

Collaborations

Kamimura has collaborated with notable colleagues such as Hiroyuki Aburatani and Yoshitaka Hippo. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Naoko Kamimura is a trailblazer in cancer research, with her patents paving the way for new diagnostic and therapeutic approaches. Her work continues to impact the scientific community and offers hope for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…